Tag: pharmaceuticals
-
Laser-Immunotherapy Now in Cancer Clinical Trial
A new type of cancer treatment that precisely attacks tumors with synthetic antibodies activated by laser beams is being tested in an early-stage clinical trial.
-
Antibody Leads to Sharp Triglyceride, Cholesterol Drop
An experimental synthetic antibody was shown in a clinical trial to markedly reduce triglycerides and the types of cholesterol that contribute to heart disease.
-
Long-Acting Opioid Abuse Therapy Shown Working in Trial
An experimental long-acting drug was shown at least as effective, and in some cases superior, to the current standard of care for opioid use disorder.
-
Small-Business Grants Awarded for Neurological Diseases
A biotechnology company spun-off last year in a pharmaceutical industry merger is receiving small business research grants to advance its technology treating neurological disorders.
-
Oxford, Evotec Partner on Drug Discovery
A collaboration between University of Oxford and a German drug discovery company aims to speed promising new treatments to the market, including support for start-up enterprises.
-
RNA Drug Delivery Technique Shown Safe in Monkeys
A biotechnology company reports a drug delivery method combining nanoscale lipid particles and biocompatible polymers enables the safe production of synthetic RNA-based proteins in monkeys.
-
Zika Vaccine Clinical Trial Underway
The first of a series of clinical trials testing inactivated Zika particles as a vaccine to protect against the live Zika virus is recruiting participants.
-
Patent Awarded for Cancer-Fighting Antibody
A synthetic engineered antibody developed by MabVax Therapeutics that binds to solid tumor cells for cancer diagnostics and treatment received a U.S. patent.
-
Lilly, Institute Partner on Tuberculosis Drug Discovery
Drug maker Eli Lilly and Company is continuing its collaboration with Infectious Disease Research Institute to discovery new drugs that treat tuberculosis.
-
Health Insurance Group Forms Academic Research Network
The national organization of Blue Cross-Blue Shield health insurance providers is linking up with academic researchers to study outcomes of health care practices, including opioid abuse and cancer screenings.